Pujol J L, Grenier J, Ray P, Gautier V, Aouta M D, Michel F B
Service des Maladies respiratoires, Université de Montpellier, Hôpital Arnaud de Villeneuve.
Presse Med. 1993 Jun 19;22(22):1039-42.
Cytokeratins are intermediate filaments of the cytoskeleton that are expressed by bronchial epithelium and its neoplastic counterpart, lung cancer. A new immunoradiometric assay referred to as CYFRA 21-1 makes it possible to titrate in the serum a cytokeratin 19 fragment. This study deals with the sensitivity, specificity and applicability of this serum marker in squamous cell carcinoma. Sera from non malignant pulmonary diseases were taken as controls. In comparison with carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC T-A4) and neuron specific enolase (NSE), CYFRA 21-1 was the most accurate marker. The area under the CYFRA 21-1 ROC curve was significantly greater than those of CEA, SCC T-A4 and NSE. Using a 3.6 ng/ml threshold, as determined by the ROC curve, CYFRA 21-1 was significantly correlated with tumor mass.
细胞角蛋白是细胞骨架的中间丝,由支气管上皮及其肿瘤对应物肺癌表达。一种称为CYFRA 21-1的新型免疫放射分析方法能够在血清中滴定细胞角蛋白19片段。本研究探讨了这种血清标志物在鳞状细胞癌中的敏感性、特异性和适用性。将非恶性肺部疾病患者的血清作为对照。与癌胚抗原(CEA)、鳞状细胞癌抗原(SCC T-A4)和神经元特异性烯醇化酶(NSE)相比,CYFRA 21-1是最准确的标志物。CYFRA 21-1的ROC曲线下面积显著大于CEA、SCC T-A4和NSE的曲线下面积。根据ROC曲线确定的3.6 ng/ml阈值,CYFRA 21-1与肿瘤大小显著相关。